We are developing novel integrin-based therapeutics.

Joined February 2016
278 Photos and videos
Excited to present FORTIFY to the global oncology community at the 2026 @ASCO ) Annual Meeting. Presentation details: ir.pliantrx.com/news-release…
57
Today, we announced our First Quarter 2026 Financial Results and provided a company update. Read the press release here: ir.pliantrx.com/news-release…
54
Pliant team members will be participating in a fireside chat with @RBC Capital Markets’ Brian Abrahams on Tuesday, May 19, 2026 at 11:30 p.m. ET as part of the 2026 RBC Capital Markets Global Healthcare Conference. Details: ir.pliantrx.com/news-release… #RBCHealthcare
46
First patient dosed in our FORTIFY trial of PLN-101095 in patients with ICI-refractory solid tumors. Read more about FORTIFY, today’s news and how Pliant is focused on addressing underserved areas of medical need: ir.pliantrx.com/news-release…
65
In an oral presentation today,@UTMDAnderson's Dr. Timothy Yap presented updated results from our Phase 1 trial of PLN-101095 in patients with ICI-refractory solid tumors as part of the @AACR 2026 Annual Meeting. Review the data and presentation lnkd.in/gCvrb5fQ #AACR26
133
Pleased that data from our Phase 1 clinical trial of PLN-101095 was selected for an oral presentation as part of the Clinical Trials Mini Symposium session at the 2026 @AACR Annual Meeting. Presentation details ir.pliantrx.com/news-release… #AACR26
125
Today we announced our Fourth Quarter 2025 Financial Results and provided a company update. Review the press release here: lnkd.in/g23DEQ-R
50
Pliant will participate in a fireside chat on Wednesday, February 25, 2026, at 2:40 p.m. E.T. at Oppenheimer & Company's 36th Annual Healthcare Life Sciences Conference. #OPCOLifeSciences Details: ir.pliantrx.com/news-release…
1
66
Join a collaborative team focused on improving the lives of patients. We are looking for a strategic regulatory leader with extensive oncology expertise to shape the future of our oncology program. Apply here: pliantrx.com/jobs/senior-dir… #Oncology #RegulatoryAffairs #HiringNow
64
Today we announced encouraging interim data from PLN-101095 in patients with immune checkpoint inhibitor-refractory solid tumors. Press release lnkd.in/gZqX99PC and listen to discussion today at 12:30 pm ET: lnkd.in/gep-MAFx.
1
78
Pliant team members will be participating in a fireside chat on Thursday, December 4, 2025 at 12:30 p.m. ET as part of Piper Sandler’s 37th Annual Healthcare Conference. Details: ir.pliantrx.com/news-release…
70
Today we announced our Third Quarter 2025 Financial Results and provided a company update. Review the press release here ir.pliantrx.com/news-release…
70
Today, we announced our Second Quarter 2025 Financial Results and provided a company update. Read the press release here: ir.pliantrx.com/news-release…
1
2
137
A productive week at the @atscommunity's 2025 International Conference featured pre-clinical and clinical work from our teams. Learn more and access the presentation and posters ir.pliantrx.com/news-release… #ATS2025
1
1
218
Today, we announced our First Quarter 2025 Financial Results and provided a company update. Read press release here: ir.pliantrx.com/news-release…
146
Today, we announced three upcoming presentations at the American Thoracic Society's 2025 International Conference, taking place May 16-21 in San Francisco, California. Read the press release here: ir.pliantrx.com/news-release… #ATS2025 @atscommunity
4
1
4
937
We are pleased to announce interim data from our Phase 1 trial of PLN-101095 in patients with immune checkpoint inhibitor- refractory advanced or metastatic solid tumors. Read the press release here: ir.pliantrx.com/news-release…
1
1
209
Today we announced our Fourth Quarter 2024 Financial Results and provided a company update. Read press release here: ir.pliantrx.com/news-release…
1
226
Happy New Lunar Year! Today, we celebrated the Year of the Snake with a special lunch, bringing our team together to enjoy delicious Chinese cuisine & embracing the unique stories that enrich our workplace culture. Wishing everyone wisdom, growth, and prosperity! #YearOfTheSnake
1
696
We’re thrilled to welcome Dr. Delphine Imbert as our new Chief Technical Officer! She brings a wealth of experience in CMC technical operations and joins at a pivotal time as we advance bexotegrast towards commercialization. Learn more about Dr. Imbert: ir.pliantrx.com/news-release…
1
658